Area of research
Oncology · Cancer Research
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Cancer Research and Treatments, and Epigenetics and DNA Methylation.
A practical framework for operationalising responsible and equitable artificial intelligence in health care: tackling bias, inequity, and implementation challenges
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
Association of Genetic Liability to Allergic Diseases with Overall and Early-Onset Colorectal Cancer Risk: A Mendelian Randomization Study
Adiposity distribution and risks of 12 obesity-related cancers: a Mendelian randomization analysis
Value of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort Studies
Early results of the PASS-01 trial: Pancreatic adenocarcinoma signature stratification for treatment-01.
Adjuvant and neoadjuvant therapies for hepatocellular carcinoma
Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysis
Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomisation analysis
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma